Electronic Medicinal Product Information (ePI) FHIR Implementation Guide
1.0.0-ballot - STU Ballot International flag

This page is part of the Electronic Medicinal Product Information (ePI) FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR v5.0.0-ballot. . For a full list of available versions, see the Directory of published versions

: warninghypotension - JSON Representation

Raw json | Download


{
  "resourceType" : "ClinicalUseDefinition",
  "id" : "ac21a804-cafa-41ff-b644-a14c8003edeb",
  "meta" : {
    "profile" : [
      "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-warning-uv-epi"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: ClinicalUseDefinition</b><a name=\"ac21a804-cafa-41ff-b644-a14c8003edeb\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource ClinicalUseDefinition &quot;ac21a804-cafa-41ff-b644-a14c8003edeb&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ClinicalUseDefinition-warning-uv-epi.html\">ClinicalUseDefinition Warning (ePI)</a></p></div><p><b>identifier</b>: id: hypotension (use: OFFICIAL)</p><p><b>type</b>: warning</p><p><b>subject</b>: <a href=\"MedicinalProductDefinition-800a51a2-d81d-49a4-a4eb-f2417d301837.html\">MedicinalProductDefinition/800a51a2-d81d-49a4-a4eb-f2417d301837</a></p><h3>Warnings</h3><table class=\"grid\"><tr><td>-</td><td><b>Description</b></td></tr><tr><td>*</td><td>Intravascular volume depletion: symptomatic hypotension, especially after the first dose, may occur in patients who are volume and/or sodium depleted by vigorous diuretic therapy, dietary salt restriction, diarrhoea or vomiting. Such conditions should be corrected before the administration of cava.</td></tr></table></div>"
  },
  "identifier" : [
    {
      "use" : "official",
      "system" : "https://spor.ema.europa.eu/rmswi#",
      "value" : "hypotension"
    }
  ],
  "type" : "warning",
  "subject" : [
    {
      "reference" : "MedicinalProductDefinition/800a51a2-d81d-49a4-a4eb-f2417d301837"
    }
  ],
  "warning" : {
    "description" : "Intravascular volume depletion: symptomatic hypotension, especially after the first dose, may occur in patients who are volume and/or sodium depleted by vigorous diuretic therapy, dietary salt restriction, diarrhoea or vomiting. Such conditions should be corrected before the administration of cava."
  }
}